| Aedes aegypti |
Aedes aegypti |
LD50 |
8.13 |
ug |
10.3390/toxins2081943 |
| Bacillus subtilis |
Bacillus subtilis |
MIC |
500.0 |
ug.mL-1 |
10.1007/s00044-013-0541-4 |
| Blumeria graminis |
Blumeria graminis |
Activity |
0.0 |
% |
10.1016/S0261-2194(00)00172-1 |
| Bos taurus |
Serum albumin |
Activity |
50.0 |
% |
10.1016/j.bmcl.2012.09.056 |
| Botrytis cinerea |
Botrytis cinerea |
Activity |
0.0 |
% |
10.1016/S0261-2194(00)00172-1 |
| Candida albicans |
Candida albicans |
IZ |
23.0 |
mm |
10.1016/j.ejmech.2019.04.002 |
| Candida albicans |
Candida albicans |
MIC |
3125.0 |
ug.mL-1 |
10.1016/j.ejmech.2019.04.002 |
| Cricetinae |
Hamster |
Activity |
3.89 |
% |
10.1021/acs.jnatprod.1c00565 |
| Danio rerio |
Danio rerio |
Activity |
nan |
None |
10.1021/acs.jnatprod.7b00081 |
| Danio rerio |
Danio rerio |
MTD |
12.0 |
uM |
10.1021/acs.jnatprod.7b00081 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
-0.1 |
% |
10.1016/j.bmc.2012.09.040 |
| Equus caballus |
Cholinesterase |
Inhibition |
16.77 |
% |
10.1016/j.bmc.2012.09.040 |
| Escherichia coli |
Escherichia coli |
IZ |
20.0 |
mm |
10.1016/j.ejmech.2019.04.002 |
| Escherichia coli |
Escherichia coli |
MIC |
300.0 |
ug.mL-1 |
10.1007/s00044-013-0541-4 |
| Escherichia coli |
Escherichia coli |
MIC |
6250.0 |
ug.mL-1 |
10.1016/j.ejmech.2019.04.002 |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Potency |
44668.4 |
nM |
None |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
140000.0 |
nM |
10.1016/j.bmcl.2013.01.118 |
| Hepatitis B virus |
Hepatitis B virus |
IC50 |
150000.0 |
nM |
10.1016/j.bmcl.2013.01.118 |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
A549 |
IC50 |
11890.0 |
nM |
10.1039/C6MD00606J |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Arachidonate 5-lipoxygenase |
IC50 |
54000.0 |
nM |
10.1016/j.bmc.2019.06.040 |
| Homo sapiens |
Arachidonate 5-lipoxygenase |
Inhibition |
47.45 |
% |
10.1016/j.bmc.2018.12.043 |
| Homo sapiens |
Aryl hydrocarbon receptor |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
10318.3 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
11577.4 |
nM |
None |
| Homo sapiens |
Bel-7402 |
IC50 |
10000.0 |
nM |
10.1021/acs.jnatprod.0c00599 |
| Homo sapiens |
Bel7402/5-FU |
IC50 |
nan |
None |
10.1021/acs.jnatprod.0c00599 |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Breast cancer type 1 susceptibility protein |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Cathepsin D |
IC50 |
42300.0 |
nM |
10.1007/s00044-012-0397-z |
| Homo sapiens |
COLO 205 |
IC50 |
46000.0 |
nM |
10.1007/s00044-010-9500-5 |
| Homo sapiens |
Cytochrome P450 1A1 |
Inhibition |
42.0 |
% |
10.1039/C7MD00388A |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Dihydroorotate dehydrogenase |
IC50 |
880.0 |
nM |
10.1016/j.ejmech.2022.114176 |
| Homo sapiens |
Dihydroorotate dehydrogenase |
Ki |
710.0 |
nM |
10.1016/j.ejmech.2022.114176 |
| Homo sapiens |
DLD-1 |
IC50 |
200000.0 |
nM |
10.1016/j.ejmech.2020.113149 |
| Homo sapiens |
DNA polymerase iota |
Potency |
89125.1 |
nM |
None |
| Homo sapiens |
DU-145 |
IC50 |
50000.0 |
nM |
10.1007/s00044-010-9500-5 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
GABA-A receptor; alpha-1/beta-2/gamma-2 |
EC50 |
5800.0 |
nM |
10.1021/acs.jnatprod.1c00840 |
| Homo sapiens |
GABA-A receptor; alpha-1/beta-2/gamma-2 |
EC50 |
52400.0 |
nM |
10.1021/jm5002277 |
| Homo sapiens |
GABA-A receptor; alpha-1/beta-2/gamma-2 |
Imax |
302.0 |
% |
10.1021/jm5002277 |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
HCT-116 |
IC50 |
200000.0 |
nM |
10.1016/j.ejmech.2020.113149 |
| Homo sapiens |
HCT-116 |
IC50 |
nan |
None |
10.1021/acs.jnatprod.0c00599 |
| Homo sapiens |
HeLa |
IC50 |
950.0 |
nM |
10.1007/s00044-013-0541-4 |
| Homo sapiens |
HeLa |
IC50 |
19210.0 |
nM |
10.1039/C6MD00606J |
| Homo sapiens |
HEp-2 |
IC50 |
70000.0 |
nM |
10.1007/s00044-010-9500-5 |
| Homo sapiens |
HepG2 |
Activity |
36.0 |
% |
10.1021/acs.jnatprod.0c01018 |
| Homo sapiens |
HepG2 |
Activity |
nan |
None |
10.1021/acs.jnatprod.0c01018 |
| Homo sapiens |
HepG2 |
IC50 |
10000.0 |
nM |
10.1021/acs.jnatprod.0c00599 |
| Homo sapiens |
HGC-27 |
IC50 |
nan |
None |
10.1021/acs.jnatprod.0c00599 |
| Homo sapiens |
Histone deacetylase 6 |
IC50 |
1044.0 |
nM |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
61.24 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
101.02 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
115.26 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
AUC |
3370.0 |
ng.hr.mL-1 |
10.1007/bf03226378 |
| Homo sapiens |
Homo sapiens |
AUC |
5300.0 |
ng.hr.mL-1 |
10.1007/bf03226378 |
| Homo sapiens |
Homo sapiens |
Cmax |
1401.84 |
nM |
10.1007/bf03226378 |
| Homo sapiens |
Homo sapiens |
ka |
1.41 |
/hr |
10.1007/bf03226378 |
| Homo sapiens |
Homo sapiens |
Kel |
0.08 |
/hr |
10.1007/bf03226378 |
| Homo sapiens |
Homo sapiens |
Tmax |
2.5 |
hr |
10.1007/bf03226378 |
| Homo sapiens |
HUVEC |
Activity |
98.0 |
% |
10.1039/C2MD20216F |
| Homo sapiens |
HUVEC |
IC50 |
100000.0 |
nM |
10.1039/C2MD20216F |
| Homo sapiens |
HUVEC |
MTD |
250.0 |
uM |
10.1039/C2MD20216F |
| Homo sapiens |
IMR-32 |
IC50 |
10190.0 |
nM |
10.1039/C6MD00606J |
| Homo sapiens |
IMR-32 |
IC50 |
89000.0 |
nM |
10.1007/s00044-010-9500-5 |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
MCF7 |
IC50 |
990.0 |
nM |
10.1007/s00044-013-0541-4 |
| Homo sapiens |
MCF7 |
IC50 |
12960.0 |
nM |
10.1039/C6MD00606J |
| Homo sapiens |
MCF7 |
IC50 |
99000.0 |
nM |
10.1007/s00044-010-9500-5 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
58.45 |
ug.mL-1 |
10.1007/s00044-012-0397-z |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
58980.0 |
nM |
10.1016/j.bmcl.2012.09.056 |
| Homo sapiens |
Monoamine oxidase A |
Inhibition |
50.0 |
% |
10.1016/j.ejmech.2019.111770 |
| Homo sapiens |
Monoamine oxidase B |
IC50 |
483.0 |
nM |
10.1016/j.bmcl.2012.09.056 |
| Homo sapiens |
Monoamine oxidase B |
IC50 |
1050.0 |
nM |
10.1016/j.ejmech.2019.111770 |
| Homo sapiens |
Niemann-Pick C1 protein |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
2433.7 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
20596.2 |
nM |
None |
| Homo sapiens |
PBMC |
Activity |
7.0 |
% |
10.1016/j.ejmech.2010.04.033 |
| Homo sapiens |
PBMC |
Activity |
10.0 |
% |
10.1016/j.ejmech.2010.04.033 |
| Homo sapiens |
PC-3 |
IC50 |
50000.0 |
nM |
10.1007/s00044-010-9500-5 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111770 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
15500.0 |
nM |
10.1124/jpet.102.034728 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
74100.0 |
nM |
10.1124/jpet.102.034728 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
nan |
None |
10.1039/C4MD00196F |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.111770 |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
SH-SY5Y |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111770 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
186.17 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
97.82 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Survival motor neuron protein |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
SW480 |
IC50 |
200000.0 |
nM |
10.1016/j.ejmech.2020.113149 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
Vanilloid receptor |
Activity |
10.0 |
uM |
10.1038/nchembio0705-85 |
| Homo sapiens |
Vanilloid receptor |
Activity |
nan |
None |
10.1016/j.bmc.2010.03.013 |
| Homo sapiens |
Vanilloid receptor |
EC50 |
3162.28 |
nM |
10.1016/j.bmc.2010.03.013 |
| Homo sapiens |
Vanilloid receptor |
Emax |
91.0 |
% |
10.1016/j.bmc.2010.03.013 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
IZ |
15.0 |
mm |
10.1016/j.ejmech.2019.04.002 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
200.0 |
ug.mL-1 |
10.1007/s00044-013-0541-4 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
MIC |
25000.0 |
ug.mL-1 |
10.1016/j.ejmech.2019.04.002 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
14500.0 |
nM |
10.1016/j.bmcl.2015.05.068 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
752000.0 |
nM |
10.1016/j.ejmech.2010.04.033 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
2558000.0 |
nM |
10.1016/j.ejmech.2010.04.033 |
| Mus musculus |
3T3-L1 |
Activity |
-14.2 |
% |
10.1016/j.bmcl.2008.04.052 |
| Mus musculus |
3T3-L1 |
Activity |
-3.9 |
% |
10.1016/j.bmcl.2008.04.052 |
| Mus musculus |
3T3-L1 |
Activity |
-1.2 |
% |
10.1016/j.bmcl.2008.04.052 |
| Mus musculus |
Hepatocyte |
Activity |
29.2 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
Activity |
36.5 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
Activity |
40.6 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
Activity |
72.4 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
Activity |
76.1 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
Activity |
84.3 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
IC50 |
12000.0 |
nM |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
-9.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
2.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
6.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
9.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
23.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
23.0 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
Inhibition |
46.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
46.0 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Hepatocyte |
Inhibition |
68.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Hepatocyte |
Inhibition |
68.0 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
L929 |
Activity |
64.0 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
L929 |
Activity |
66.2 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
L929 |
Activity |
92.2 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
L929 |
IC50 |
42000.0 |
nM |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
L929 |
Inhibition |
5.3 |
% |
10.1016/j.bmc.2010.01.047 |
| Mus musculus |
L929 |
Inhibition |
5.5 |
% |
10.1016/j.bmc.2010.01.047 |
| Mus musculus |
L929 |
Inhibition |
10.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
L929 |
Inhibition |
10.6 |
% |
10.1016/j.bmc.2010.01.047 |
| Mus musculus |
L929 |
Inhibition |
17.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
L929 |
Inhibition |
22.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
L929 |
Inhibition |
41.8 |
% |
10.1016/j.bmc.2010.01.047 |
| Mus musculus |
L929 |
Inhibition |
82.0 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Monoamine oxidase A |
Ki |
19000.0 |
nM |
10.1016/j.bmcl.2009.11.106 |
| Mus musculus |
Monoamine oxidase B |
Ki |
3190.0 |
nM |
10.1016/j.bmcl.2009.11.106 |
| Mus musculus |
Mus musculus |
Activity |
27.5 |
% |
10.1021/acs.jnatprod.0c01018 |
| Mus musculus |
Mus musculus |
Activity |
34.4 |
% |
10.1021/acs.jnatprod.0c01018 |
| Mus musculus |
Mus musculus |
Activity |
43.6 |
% |
10.1021/acs.jnatprod.0c01018 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/acs.jnatprod.0c01018 |
| Mus musculus |
Mus musculus |
Inhibition |
-2.2 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
-2.2 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
0.3 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
0.3 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
9.2 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
9.2 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
15.7 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
15.7 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
23.2 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
23.2 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
50.7 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
50.7 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
51.1 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
51.1 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
94.3 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
94.3 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Mus musculus |
Inhibition |
96.1 |
% |
10.1016/j.bmc.2009.08.050 |
| Mus musculus |
Mus musculus |
Inhibition |
96.1 |
% |
10.1016/j.bmcl.2008.01.101 |
| Mus musculus |
Nuclear receptor ROR-gamma |
Potency |
5623.4 |
nM |
None |
| Mus musculus |
RAW264.7 |
Inhibition |
49.67 |
% |
10.1016/j.ejmech.2015.01.001 |
| Mus musculus |
Serum |
Cmax |
19170.11 |
nM |
10.1007/bf03226378 |
| Mus musculus |
Serum |
Tmax |
6.0 |
hr |
10.1007/bf03226378 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
2.62 |
ug.mL-1 |
10.1021/acs.jnatprod.0c01195 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
1.74 |
ug.mL-1 |
10.1021/acs.jnatprod.0c01195 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
128.0 |
ug.mL-1 |
10.1016/j.ejmech.2017.06.005 |
| Photinus pyralis |
Luciferin 4-monooxygenase |
Potency |
8492.1 |
nM |
None |
| Phytophthora infestans |
Phytophthora infestans |
Activity |
0.0 |
% |
10.1016/S0261-2194(00)00172-1 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
4653.5 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
7375.3 |
nM |
None |
| Proteus vulgaris |
Proteus vulgaris |
IZ |
17.0 |
mm |
10.1016/j.ejmech.2019.04.002 |
| Proteus vulgaris |
Proteus vulgaris |
MIC |
12500.0 |
ug.mL-1 |
10.1016/j.ejmech.2019.04.002 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
IZ |
8.0 |
mm |
10.1016/j.ejmech.2019.04.002 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
100.0 |
ug.mL-1 |
10.1007/s00044-013-0541-4 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
100000.0 |
ug.mL-1 |
10.1016/j.ejmech.2019.04.002 |
| Puccinia recondita |
Puccinia recondita |
Activity |
0.0 |
% |
10.1016/S0261-2194(00)00172-1 |
| Pyricularia grisea |
Pyricularia grisea |
Activity |
0.0 |
% |
10.1016/S0261-2194(00)00172-1 |
| Rattus norvegicus |
Monoamine oxidase A |
IC50 |
404.0 |
nM |
10.1016/j.bmcl.2012.02.090 |
| Rattus norvegicus |
Monoamine oxidase A |
Ki |
49300.0 |
nM |
10.1016/j.bmcl.2009.11.106 |
| Rattus norvegicus |
Monoamine oxidase B |
IC50 |
260.0 |
nM |
10.1016/j.bmcl.2012.02.090 |
| Rattus norvegicus |
Monoamine oxidase B |
Ki |
91300.0 |
nM |
10.1016/j.bmcl.2009.11.106 |
| Rattus norvegicus |
Nuclear receptor subfamily 1 group I member 2 |
Potency |
7079.5 |
nM |
None |
| Rattus norvegicus |
PC-12 |
Activity |
55.72 |
% |
10.1016/j.ejmech.2020.112385 |
| Rattus norvegicus |
PC-12 |
Activity |
nan |
None |
10.1021/np300911b |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.67 |
ml |
10.1016/j.ejmech.2015.01.001 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
0.676 |
ml |
10.1016/j.ejmech.2015.01.001 |
| Rattus norvegicus |
Rattus norvegicus |
Activity |
nan |
None |
10.1016/j.ejmech.2015.01.001 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
53.69 |
% |
10.1016/j.ejmech.2015.01.001 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
54.72 |
% |
10.1016/j.ejmech.2015.01.001 |
| Rhizoctonia solani |
Rhizoctonia solani |
Activity |
0.0 |
% |
10.1016/S0261-2194(00)00172-1 |
| Salmonella enterica subsp. enterica serovar Typhi |
Salmonella typhi |
MIC |
200.0 |
ug.mL-1 |
10.1007/s00044-013-0541-4 |
| Schistosoma mansoni |
Thioredoxin glutathione reductase |
Potency |
39810.7 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
16.44 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
22.14 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-5.85 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.04 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.22 |
% |
10.6019/CHEMBL4495565 |
| Shigella dysenteriae |
Shigella dysenteriae |
MIC |
600.0 |
ug.mL-1 |
10.1007/s00044-013-0541-4 |
| Staphylococcus aureus |
Fluoroquinolone resistance protein |
FC |
0.0 |
None |
10.1039/C4MD00196F |
| Staphylococcus aureus |
Fluoroquinolone resistance protein |
MIC |
256.0 |
ug.mL-1 |
10.1039/C4MD00196F |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
0.0 |
None |
10.1016/j.bmcl.2016.07.062 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1016/j.bmc.2008.09.042 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1016/j.bmcl.2016.07.062 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1016/j.ejmech.2009.05.004 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1016/j.ejmech.2010.05.006 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1039/C4MD00196F |
| Staphylococcus aureus |
Quinolone resistance protein norA |
logPF |
1.78 |
None |
10.1016/j.ejmech.2009.05.004 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MEC |
25.0 |
ug ml-1 |
10.1016/j.bmcl.2016.07.062 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MEC |
25.0 |
ug ml-1 |
10.1016/j.ejmech.2009.05.004 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MEC |
50.0 |
ug ml-1 |
10.1016/j.bmcl.2016.07.062 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MEC |
50.0 |
ug ml-1 |
10.1016/j.ejmech.2010.05.006 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2008.05.030 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MIC |
4.0 |
ug.mL-1 |
10.1039/C4MD00196F |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MIC |
100.0 |
ug.mL-1 |
10.1016/j.ejmech.2009.05.004 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
PF |
60.0 |
None |
10.1016/j.ejmech.2009.05.004 |
| Staphylococcus aureus |
Staphylococcus aureus |
IC50 |
72300.0 |
nM |
10.1021/acs.jnatprod.7b00654 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
12.0 |
mm |
10.1016/j.ejmech.2019.04.002 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
50.0 |
ug.mL-1 |
10.1016/j.bmcl.2016.07.062 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
300.0 |
ug.mL-1 |
10.1007/s00044-013-0541-4 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
50000.0 |
ug.mL-1 |
10.1016/j.ejmech.2019.04.002 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
119000.0 |
nM |
10.1021/acs.jnatprod.7b00654 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
4910.0 |
nM |
10.1016/j.bmc.2007.12.049 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
4910.0 |
nM |
10.1016/j.bmcl.2004.04.019 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
5000.0 |
nM |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
7310.0 |
nM |
10.1016/j.bmc.2007.12.049 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
7360.0 |
nM |
10.1016/j.bmcl.2004.04.019 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
233000.0 |
nM |
10.1007/s00044-008-9161-9 |
| Trypanosoma cruzi |
Trypanothione reductase |
Inhibition |
11.0 |
% |
10.1016/j.bmc.2008.05.074 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/acs.jnatprod.0c01018 |
| None |
ADMET |
CC50 |
2350000.0 |
nM |
10.1016/j.bmcl.2013.01.118 |
| None |
ADMET |
LD50 |
20.01 |
uM |
10.1016/j.bmc.2007.12.049 |
| None |
ADMET |
log Pe |
-3.87 |
None |
10.1016/j.bmcl.2012.09.056 |
| None |
Molecular identity unknown |
Potency |
28183.8 |
nM |
None |
| None |
No relevant target |
CHI |
73.45 |
None |
10.1016/j.ejmech.2019.111770 |
| None |
No relevant target |
LogD |
2.39 |
None |
10.1016/j.ejmech.2019.111770 |
| None |
No relevant target |
-log(solubility) |
4.15 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
4.36 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
4.55 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
4.85 |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
-log(solubility) |
nan |
None |
10.1016/j.bmcl.2015.02.013 |
| None |
No relevant target |
Retention_time |
10.61 |
min |
10.1016/j.ejmech.2019.111770 |
| None |
Nucleic Acid |
Binding |
56.6 |
pM 30min-1 (mg of DNA)-1 |
10.1016/0960-894X(95)00272-U |
| None |
Nucleic Acid |
Binding |
70.0 |
pM 30min-1 (mg of DNA)-1 |
10.1016/0960-894X(95)00272-U |
| None |
Nucleic Acid |
Binding |
96.6 |
pM 30min-1 (mg of DNA)-1 |
10.1016/0960-894X(95)00272-U |
| None |
Nucleic Acid |
Inhibition |
27.0 |
% |
10.1016/0960-894X(95)00272-U |
| None |
Nucleic Acid |
Inhibition |
47.0 |
% |
10.1016/0960-894X(95)00272-U |
| None |
Nucleic Acid |
Inhibition |
57.0 |
% |
10.1016/0960-894X(95)00272-U |
| None |
Peritoneal macrophage cell |
Inhibition |
2.0 |
% |
10.1016/j.bmc.2009.08.050 |
| None |
Peritoneal macrophage cell |
Inhibition |
11.0 |
% |
10.1016/j.bmc.2009.08.050 |
| None |
Peritoneal macrophage cell |
Inhibition |
49.0 |
% |
10.1016/j.bmc.2009.08.050 |
| None |
Unchecked |
Activity |
80.0 |
% |
10.1021/acs.jnatprod.0c01018 |
| None |
Unchecked |
Activity |
204.0 |
% |
10.1021/np900656g |
| None |
Unchecked |
Activity |
226.0 |
% |
10.1021/np900656g |
| None |
Unchecked |
Activity |
302.0 |
% |
10.1021/np900656g |
| None |
Unchecked |
Activity |
334.0 |
% |
10.1021/np900656g |
| None |
Unchecked |
Activity |
391.0 |
% |
10.1021/np900656g |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jnatprod.0c01018 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/np900656g |
| None |
Unchecked |
EC50 |
52000.0 |
nM |
10.1021/np900656g |
| None |
Unchecked |
FC |
0.0 |
None |
10.1039/C4MD00196F |
| None |
Unchecked |
FC |
1.8 |
None |
10.1021/acs.jnatprod.0c01018 |
| None |
Unchecked |
FC |
7.0 |
None |
10.1016/j.ejmech.2017.06.047 |
| None |
Unchecked |
FC |
14.0 |
None |
10.1016/j.ejmech.2017.06.047 |
| None |
Unchecked |
FC |
32.0 |
None |
10.1016/j.ejmech.2017.06.047 |
| None |
Unchecked |
IC50 |
1200000.0 |
nM |
10.1021/np900656g |
| None |
Unchecked |
Inhibition |
67.3 |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
67.5 |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
75.0 |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
85.1 |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
86.6 |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
90.0 |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
90.2 |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2016.10.047 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.1c01154 |
| None |
Unchecked |
MIC |
32.0 |
ug.mL-1 |
10.1039/C4MD00196F |
| None |
Unchecked |
MIC |
64.0 |
ug.mL-1 |
10.1039/C4MD00196F |
| None |
Unchecked |
Potency |
3162.3 |
nM |
None |
| None |
Unchecked |
Potency |
5623.4 |
nM |
None |
| None |
Unchecked |
Potency |
10000.0 |
nM |
None |
| None |
Unchecked |
Potency |
20596.2 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Ratio CC50/IC50 |
15.7 |
None |
10.1016/j.bmcl.2013.01.118 |
| None |
Unchecked |
Ratio CC50/IC50 |
16.8 |
None |
10.1016/j.bmcl.2013.01.118 |
| None |
Unchecked |
Ratio IC50 |
1.55 |
None |
10.1016/j.bmcl.2012.02.090 |
| None |
Unchecked |
Ratio IC50 |
10.0 |
None |
10.1016/j.ejmech.2019.111770 |